TSX runs higher on rate cut expectations
IceCure Medical (TASE:BLWV) Ltd. (NASDAQ:ICCM) filed an amendment to its previously published proxy materials for its upcoming Special General Meeting of Shareholders, according to a press release statement based on a filing with the U.S. Securities and Exchange Commission.
The amendment, submitted Friday, replaces the original Notice of Meeting and Proxy Statement that were furnished on Monday, July 28. The sole change in the updated documents is the inclusion of the website address that shareholders will use to attend the meeting remotely. No other modifications were made to the content of the proxy materials, and Exhibit 99.3, the Proxy Card, remains unchanged.
The Special General Meeting is scheduled to be held on Monday, September 1, 2025, and will take place exclusively by remote communication. Only shareholders of record holding ordinary shares at the close of business on Monday, August 4, 2025, will be entitled to receive notice of and vote at the meeting, as well as at any postponements or adjournments.
IceCure Medical Ltd. is a medical device company incorporated outside the United States, with principal executive offices in Caesarea, Israel. The information in this article is based on the company’s press release statement and SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.